$REGN
REGENERON PHARMACEUTICALS, INC.

2018 Q2 Form 10-Q Financial Statement

#000153217618000028 Filed on August 02, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2017 Q2
Revenue $1.608B $1.470B
YoY Change 9.38% 21.23%
Cost Of Revenue $91.70M $42.13M
YoY Change 117.64% 2.15%
Gross Profit $1.516B $1.428B
YoY Change 6.19% 21.91%
Gross Profit Margin 94.3% 97.13%
Selling, General & Admin $364.8M $306.9M
YoY Change 18.86% 5.09%
% of Gross Profit 24.06% 21.49%
Research & Development $529.3M $510.0M
YoY Change 3.79% -8.92%
% of Gross Profit 34.91% 35.71%
Depreciation & Amortization $33.60M $35.10M
YoY Change -4.27% 40.4%
% of Gross Profit 2.22% 2.46%
Operating Expenses $894.1M $816.9M
YoY Change 9.45% -4.12%
Operating Profit $622.2M $550.3M
YoY Change 13.06% 88.7%
Interest Expense $6.900M $5.401M
YoY Change 27.75% -531.73%
% of Operating Profit 1.11% 0.98%
Other Income/Expense, Net $33.90M -$24.46M
YoY Change -238.58% -3995.22%
Pretax Income $656.1M $525.9M
YoY Change 24.77% 79.93%
Income Tax $104.7M $138.1M
% Of Pretax Income 15.96% 26.26%
Net Earnings $551.4M $387.7M
YoY Change 42.22% 97.59%
Net Earnings / Revenue 34.29% 26.37%
Basic Earnings Per Share $5.12 $3.66
Diluted Earnings Per Share $4.82 $3.34
COMMON SHARES
Basic Shares Outstanding 107.8M shares 106.0M shares
Diluted Shares Outstanding 114.5M shares 116.1M shares

Balance Sheet

Concept 2018 Q2 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.684B $1.268B
YoY Change 32.81% 21.34%
Cash & Equivalents $917.9M $744.3M
Short-Term Investments $766.0M $524.0M
Other Short-Term Assets $460.0M $381.0M
YoY Change 20.73% 141.14%
Inventory $928.6M $554.3M
Prepaid Expenses
Receivables $1.534B $1.420B
Other Receivables $0.00 $0.00
Total Short-Term Assets $4.815B $3.860B
YoY Change 24.74% 20.28%
LONG-TERM ASSETS
Property, Plant & Equipment $2.462B $2.262B
YoY Change 8.84% 27.57%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.045B $1.065B
YoY Change 92.02% 80.51%
Other Assets $85.67M $36.96M
YoY Change 131.77% 450.45%
Total Long-Term Assets $5.137B $4.246B
YoY Change 20.98% 41.75%
TOTAL ASSETS
Total Short-Term Assets $4.815B $3.860B
Total Long-Term Assets $5.137B $4.246B
Total Assets $9.952B $8.106B
YoY Change 22.77% 30.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $172.0M $151.0M
YoY Change 13.91% 48.04%
Accrued Expenses $671.0M $542.0M
YoY Change 23.8% 11.07%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $1.331B $1.029B
YoY Change 29.37% 8.14%
LONG-TERM LIABILITIES
Long-Term Debt $706.0M $701.0M
YoY Change 0.71% 93.65%
Other Long-Term Liabilities $190.0M $115.9M
YoY Change 63.92% -3.01%
Total Long-Term Liabilities $190.0M $115.9M
YoY Change 63.92% -3.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.331B $1.029B
Total Long-Term Liabilities $190.0M $115.9M
Total Liabilities $2.766B $2.586B
YoY Change 6.96% 21.48%
SHAREHOLDERS EQUITY
Retained Earnings $3.839B $2.385B
YoY Change 60.98% 93.85%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $353.9M $316.2M
YoY Change 11.89% 0.06%
Treasury Stock Shares 3.885M shares 3.764M shares
Shareholders Equity $7.186B $5.521B
YoY Change
Total Liabilities & Shareholders Equity $9.952B $8.106B
YoY Change 22.77% 30.64%

Cashflow Statement

Concept 2018 Q2 2017 Q2
OPERATING ACTIVITIES
Net Income $551.4M $387.7M
YoY Change 42.22% 97.59%
Depreciation, Depletion And Amortization $33.60M $35.10M
YoY Change -4.27% 40.4%
Cash From Operating Activities $394.6M -$30.60M
YoY Change -1389.54% -107.66%
INVESTING ACTIVITIES
Capital Expenditures -$112.0M -$54.80M
YoY Change 104.38% -60.52%
Acquisitions
YoY Change
Other Investing Activities -$373.0M -$115.5M
YoY Change 222.94% -38.3%
Cash From Investing Activities -$485.0M -$170.5M
YoY Change 184.46% -47.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -11.20M 133.5M
YoY Change -108.39% -527.88%
NET CHANGE
Cash From Operating Activities 394.6M -30.60M
Cash From Investing Activities -485.0M -170.5M
Cash From Financing Activities -11.20M 133.5M
Net Change In Cash -101.6M -67.60M
YoY Change 50.3% -259.81%
FREE CASH FLOW
Cash From Operating Activities $394.6M -$30.60M
Capital Expenditures -$112.0M -$54.80M
Free Cash Flow $506.6M $24.20M
YoY Change 1993.39% -95.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
regn Incremental Common Shares Attributable To Nonvested Restricted Shares
IncrementalCommonSharesAttributableToNonvestedRestrictedShares
14000 shares
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
dei Document Period End Date
DocumentPeriodEndDate
2018-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000872589
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
REGENERON PHARMACEUTICALS INC
CY2016Q4 regn Accrued Capital Expenditures
AccruedCapitalExpenditures
28200000 USD
CY2017Q2 regn Accrued Capital Expenditures
AccruedCapitalExpenditures
30900000 USD
CY2017Q4 regn Accrued Capital Expenditures
AccruedCapitalExpenditures
41800000 USD
CY2018Q2 regn Accrued Capital Expenditures
AccruedCapitalExpenditures
38400000 USD
CY2017Q4 regn Capitalandfacilityleaseobligationsnoncurrent
Capitalandfacilityleaseobligationsnoncurrent
703453000 USD
CY2018Q2 regn Capitalandfacilityleaseobligationsnoncurrent
Capitalandfacilityleaseobligationsnoncurrent
705903000 USD
CY2017Q2 regn Incremental Common Shares Attributable To Nonvested Restricted Shares
IncrementalCommonSharesAttributableToNonvestedRestrictedShares
501000 shares
regn Incremental Common Shares Attributable To Nonvested Restricted Shares
IncrementalCommonSharesAttributableToNonvestedRestrictedShares
493000 shares
CY2018Q2 regn Incremental Common Shares Attributable To Nonvested Restricted Shares
IncrementalCommonSharesAttributableToNonvestedRestrictedShares
13000 shares
CY2016Q3 regn Loss Contingency Damages Soughtperunitproduced.
LossContingencyDamagesSoughtperunitproduced.
10000 EUR
CY2017Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
242014000 USD
CY2018Q2 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
261685000 USD
CY2017Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
178183000 USD
CY2018Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
171906000 USD
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1538642000 USD
CY2018Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1534324000 USD
CY2017Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
193684000 USD
CY2018Q2 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
243238000 USD
CY2017Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
637162000 USD
CY2018Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
670709000 USD
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
640000 USD
CY2018Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11612000 USD
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3512833000 USD
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3712599000 USD
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-311344000 USD
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-16084000 USD
CY2017Q4 us-gaap Assets
Assets
8764286000 USD
CY2018Q2 us-gaap Assets
Assets
9951980000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
4335030000 USD
CY2018Q2 us-gaap Assets Current
AssetsCurrent
4814917000 USD
CY2017Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2210000 USD
CY2018Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2312000 USD
CY2017Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
8926000 USD
CY2018Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
20584000 USD
CY2017Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2027272000 USD
CY2018Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2743029000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
1426773000 USD
CY2018Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
1959115000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
593783000 USD
CY2018Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
765642000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2020556000 USD
CY2018Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2724757000 USD
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
201200000 USD
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
744313000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
812733000 USD
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
917876000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
209110000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
105143000 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
547703000 USD
CY2017Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
756813000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
825233000 USD
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
930376000 USD
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
395976000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
651863000 USD
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
555394000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1023733000 USD
CY2017Q2 us-gaap Costs And Expenses
CostsAndExpenses
919804000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1808253000 USD
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
985834000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1930088000 USD
CY2017Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
326676000 USD
CY2018Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
289973000 USD
CY2017Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
3583000 USD
CY2018Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
4868000 USD
CY2017Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
1044084000 USD
CY2018Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
1636873000 USD
CY2017Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
5343000 USD
CY2018Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
15716000 USD
CY2017Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
1370760000 USD
CY2018Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
1926846000 USD
CY2017Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
8926000 USD
CY2018Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
20584000 USD
CY2017Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
506291000 USD
CY2018Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
545077000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
73241000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
70000000 USD
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.02
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
9.56
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.51
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.82
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
8.97
CY2017Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.263
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.336
CY2018Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.160
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.171
CY2017Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
5800000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
11200000 USD
CY2018Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
16500000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
25900000 USD
CY2017Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0 USD
CY2018Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0 USD
CY2017Q2 us-gaap Gain Loss On Interest Rate Cash Flow Hedge Ineffectiveness
GainLossOnInterestRateCashFlowHedgeIneffectiveness
0 USD
us-gaap Gain Loss On Interest Rate Cash Flow Hedge Ineffectiveness
GainLossOnInterestRateCashFlowHedgeIneffectiveness
0 USD
CY2018Q2 us-gaap Gain Loss On Interest Rate Cash Flow Hedge Ineffectiveness
GainLossOnInterestRateCashFlowHedgeIneffectiveness
0 USD
us-gaap Gain Loss On Interest Rate Cash Flow Hedge Ineffectiveness
GainLossOnInterestRateCashFlowHedgeIneffectiveness
0 USD
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
525850000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
958139000 USD
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
656074000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1241472000 USD
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
138106000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
321464000 USD
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
104662000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
212080000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-147232000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
66979000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
232927000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
64907000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-10655000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-84238000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
57737000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
15487000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
151544000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
182100000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
77168000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-59432000 USD
CY2017Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
9602000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
9310000 shares
CY2018Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
6664000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
6959000 shares
CY2017Q2 us-gaap Interest Expense
InterestExpense
5401000 USD
us-gaap Interest Expense
InterestExpense
12902000 USD
CY2018Q2 us-gaap Interest Expense
InterestExpense
6918000 USD
us-gaap Interest Expense
InterestExpense
13357000 USD
CY2017Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
21791000 USD
CY2018Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
26571000 USD
CY2017Q4 us-gaap Inventory Net
InventoryNet
726138000 USD
CY2018Q2 us-gaap Inventory Net
InventoryNet
928553000 USD
CY2017Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
190045000 USD
CY2018Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
205463000 USD
CY2017Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
302042000 USD
CY2018Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
400834000 USD
CY2018Q2 us-gaap Legal Fees
LegalFees
10500000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
2620208000 USD
CY2018Q2 us-gaap Liabilities
Liabilities
2765554000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8764286000 USD
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9951980000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1135483000 USD
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1331190000 USD
CY2016Q3 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
10000000 EUR
CY2017Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
596847000 USD
CY2018Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
765642000 USD
CY2017Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
1486494000 USD
CY2018Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
2044703000 USD
CY2017Q2 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 USD
CY2018Q2 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
194331000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2220000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-310552000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-910385000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
325331000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1013308000 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
387744000 USD
us-gaap Net Income Loss
NetIncomeLoss
636675000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
551412000 USD
us-gaap Net Income Loss
NetIncomeLoss
1029392000 USD
CY2017Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-24462000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-22715000 USD
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
33886000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
52053000 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
550312000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
980854000 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
622188000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1189419000 USD
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
77866000 USD
CY2018Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
85669000 USD
CY2017Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
28000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
28000 USD
CY2018Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
608000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
2047000 USD
CY2017Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
8204000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
15160000 USD
CY2018Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3374000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-7706000 USD
CY2017Q4 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
212260000 USD
CY2018Q2 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
295685000 USD
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
152073000 USD
CY2018Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
190020000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-37631000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
54980000 USD
CY2017Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-19061000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9813000 USD
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
40804000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
65410000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
31437000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
31853000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
477408000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1181205000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
105310000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
191392000 USD
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
224972000 USD
CY2018Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
163599000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
188693000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
34073000 USD
us-gaap Proceeds From Repayments Of Long Term Debt And Capital Securities
ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities
57000000 USD
us-gaap Proceeds From Repayments Of Long Term Debt And Capital Securities
ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities
0 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
272166000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
462212000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2358605000 USD
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2461614000 USD
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
19925000 USD
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
0 USD
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
509975000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1017410000 USD
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
529289000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1027875000 USD
CY2017Q2 us-gaap Restricted Cash
RestrictedCash
12500000 USD
CY2018Q2 us-gaap Restricted Cash
RestrictedCash
12500000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2946733000 USD
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3839179000 USD
CY2017Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1470116000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2789107000 USD
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1608022000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3119507000 USD
CY2017Q4 us-gaap Securities Owned Not Readily Marketable
SecuritiesOwnedNotReadilyMarketable
37500000 USD
CY2018Q2 us-gaap Securities Owned Not Readily Marketable
SecuritiesOwnedNotReadilyMarketable
45500000 USD
CY2017Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
306908000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
603754000 USD
CY2018Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
364884000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
695654000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
255047000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
189217000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
6144078000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
7186426000 USD
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
3763868 shares
CY2018Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
3885469 shares
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
316240000 USD
CY2018Q2 us-gaap Treasury Stock Value
TreasuryStockValue
353852000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
37600000 USD
CY2016Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
45851000 USD
CY2017Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
55028000 USD
CY2017Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
85302000 USD
CY2018Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
90954000 USD
us-gaap Valuation Allowances And Reserves Charged To Other Accounts
ValuationAllowancesAndReservesChargedToOtherAccounts
188858000 USD
us-gaap Valuation Allowances And Reserves Charged To Other Accounts
ValuationAllowancesAndReservesChargedToOtherAccounts
219723000 USD
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
179681000 USD
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
214071000 USD
CY2017Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
10103000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
9803000 shares
CY2018Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
6677000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
6973000 shares
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116137000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115607000 shares
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114477000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114697000 shares
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106034000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105804000 shares
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107724000 shares
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Issued Accounting Standards </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:10pt;">. The new standard requires a lessee to recognize on its balance sheet (for both finance and operating leases) a liability to make lease payments and a right-of-use asset representing its right to use the underlying asset for the lease term. The amendments are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted. We plan to adopt this standard in the first quarter of 2019 and are evaluating the impact that this guidance will have on our financial statements, including related disclosures. The new standard will result in the Company recording additional assets and corresponding liabilities related to operating leases; however, we do not expect the standard to have a material impact to our Consolidated Balance Sheets. The ultimate impact that the new standard will have will depend on the total amount of the Company's lease commitments as of the adoption date. We are in process of implementing a new lease accounting software system, and expect the implementation of the new standard to have a significant impact on our internal controls and processes.</font></div></div>

Files In Submission

Name View Source Status
0001532176-18-000028-index-headers.html Edgar Link pending
0001532176-18-000028-index.html Edgar Link pending
0001532176-18-000028.txt Edgar Link pending
0001532176-18-000028-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
regn-063018x10q.htm Edgar Link pending
regn-20180630.xml Edgar Link completed
regn-20180630.xsd Edgar Link pending
regn-20180630_cal.xml Edgar Link unprocessable
regn-20180630_def.xml Edgar Link unprocessable
regn-20180630_lab.xml Edgar Link unprocessable
regn-20180630_pre.xml Edgar Link unprocessable
regn-ex_311x06302018x10q.htm Edgar Link pending
regn-ex_312x06302018x10q.htm Edgar Link pending
regn-ex_32x06302018x10q.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending